Summary
Hypoglycaemic brain damage consists of selective necrosis of cerebral neurons related to the extracellular release of excitatory amino acids. Neuronal excitatory amino acid receptors are activated and calcium channels are opened. The present investigation was designed to test the effectiveness of dihydropyridine blockade of voltage-sensitive calcium channels in hypoglycaemic brain damage. Sixty-four rats were given either high-dose nimodipine, consisting of an initial bolus of 300 Μg/kg nimodipine administered at the stage of EEG slowing (blood glucose levels of 1.0–1.5 mmol/l), followed by continuous intravenous nimodipine infusion at 1.5 Μg · kg−1 · min−1, low-dose nimodipine, consisting of an initial bolus of 30 Μg/kg at the time of EEG slowing, followed by 0.15 Μg · kg−1 · min−1, an equal volume of vehicle solution, or 154 mmol/l NaCl. Animals receiving either low- or high-dose nimodipine had higher mortality, and increased brain damage compared with controls. Examination of the perfusion-fixed brains 1 week after recovery with glucose revealed that quantitated neuronal necrosis was worsened by nimodipine in the hippocampus, caudate nucleus and cerebral cortex. The present results in profound hypoglycaemia (accompanied by a flat EEG) contrast with the beneficial effect of nimodipine in brain ischaemia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- EAA:
-
Excitatory amino acid
- NMDA:
-
N-methyl-d-aspartate
- VSCC:
-
voltage-sensitive calcium channels
- ANOVA:
-
analysis of variance
References
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
Chan JC, Cockram CS, Nicholls MG, Cheung CK, Swaminathan R (1992) Comparison of enalapril and nifedipine in treating non-insulin dependent diabetes associated with hypertension: one year analysis. BMJ 305: 981–985
Gomis R, Vidal J, Novials A, Coves MJ (1993) Effects of isradipine and nifedipine retard in hypertensive patients with type II diabetes mellitus. Am J Hypertension 6: S102-S103
Kappelle AC, Biessels G, Bravenboer B et al. (1994) Beneficial effect of the Ca2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/W or rat. Br J Pharmacol 111: 887–893
Sandberg M, Butcher SP, Hagberg H (1986) Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: in vivo dialysis of the rat hippocampus. J Neurochem 47: 178–184
Westerberg E, Kehr J, Ungerstedt U, Wieloch T (1988) The NMDA-antagonist MK-801 reduces extracellular amino acid levels during hypoglycemia and prevents striatal damage. Neurosci Res Comm 3: 151–158
Wieloch T (1985) Hypoglycemia-induced neuronal damage prevented by an N-methyl-d-aspartate antagonist. Science 230: 681–683
Papagapiou MP, Auer RN (1990) Regional neuroprotective effects of the NMDA receptor antagonist MK-801 (dizocilpine) in hypoglycemic brain damage. J Cereb Blood Flow Metab 10: 270–276
Auer RN, Hugh J, Cosgrove E, Curry B (1989) Neuropathologic findings in three cases of profound hypoglycemia. Clin Neuropathol 8: 63–68
Kalimo H, Olsson Y (1980) Effect of severe hypoglycemia on the human brain. Acta Neurol Scand 62: 345–356
Auer RN (1986) Hypoglycemic brain damage. Stroke 17: 488–496
Deshpande JK, Wieloch T (1986) Flunarizine, a calcium entry blocker, ameliorates ischemic brain damage in the rat. Anesthesiology 64: 215–224
Germano IM, Bartkowski HM, Cassel ME, Pitts LH (1987) The therapeutic value of nimodipine in experimental focal cerebral ischemia. Neurological outcome and histopathological findings. J Neurosurg 67: 81–87
Jacewicz M, Brint S, Tanabe J, Pulsinelli W (1990) Continuous nimodipine treatment attenuates cortical infarction in rats subjected to 24 hours of focal ischemia. J Cereb Blood Flow Metab 10: 89–96
Mohamed AA, Gotoh O, Graham DI et al. (1985) Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusion. Ann Neurol 18: 705–711
Hakim AM (1986) Cerebral acidosis in focal ischemia: II. Nimodipine and verapamil normalize cerebral pH following middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 6: 676–683
Auer RN, Siesjö BK (1988) Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol 24: 699–707
Langley MS, Sorkin EM (1989) Nimodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cerebrovascular disease. Drugs 37: 669–699
Auer RN, Olsson Y, Siesjö BK (1984) Hypoglycemic brain injury in the rat. Correlation of density of brain damage with the EEG isoelectric time: a quantitative study. Diabetes 33: 1090–1098
Abdul-Rahman A, Agardh C-D, Siesjö BK (1980) Local cerebral blood flow in the rat during severe hypoglycemia and in the recovery period following glucose injection. Acta Physiol Scand 109: 307–314
Auer RN, Kalimo H, Olsson Y, Siesjö BK (1985) The temporal evolution of hypoglycemic brain damage. I. Light and electron microscopic findings in the rat cerebral cortex. Acta Neuropathol (Berl) 67: 13–24
Auer RN, Jensen ML, Whishaw IQ (1989) Neurobehavioural deficit due to ischemic brain damage limited to half of the CA1 sector of the hippocampus. J Neurosci 9: 1641–1647
Auer RN, Kalimo H, Olsson Y, Wieloch T (1985) The dentate gyrus in hypoglycemia. Pathology implicating excitotoxin-mediated neuronal necrosis. Acta Neuropathol (Berl) 67: 279–288
Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, Sydney New York London
Auer RN, Wieloch T, Olsson Y, Siesjö BK (1984) The distribution of hypoglycemic brain damage. Acta Neuropathol (Berl) 64: 177–191
Sokal RR, Rohlf FJ (1981) Biometry. The principles and practice of statistics in biological research. W.H. Freeman and Company, New York
Auer LM, Mokry M (1986) Effect of topical nimodipine versus its ethanol-containing vehicle on cat pial arteries. Stroke 17: 225–228
Woodward JJ, Machu T, Leslie SW (1990) Chronic ethanol treatment alters omega-conotoxin and Bay K 8644 sensitive calcium channels in rat striatal synaptosomes. Alcohol 7: 279–284
Brennan CH, Crabbe J, Littleton JM (1990) Genetic regulation of dihydropyridine-sensitive calcium channels in brain may determine susceptibility to physical dependence on alcohol. Neuropharmacology 29: 429–432
Whittington MA, Dolin SJ, Patch TL, Siarey RJ, Butterworth AR, Little HJ (1991) Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment. Br J Pharmacol 103: 1669–1676
Abernethy DR, Schwartz JB (1988) Pharmacokinetics of calcium antagonists under development. Clin Pharmacokinet 15: 1–14
Miller RJ (1987) Multiple calcium channels and neuronal function. Science 235: 46–52
Wong MCW, Haley EC Jr (1990) Calcium antagonists: stroke therapy coming of age. Stroke 21: 494–501
Sauter A, Rudin M (1991) Prevention of stroke and brain damage with calcium antagonists in animals. Am J Hypertens 4: 121S-127S
Pelligrino D, Siesjö BK (1981) Regulation of extra- and intracellular pH in the brain in severe hypoglycemia. J Cereb Blood Flow Metab 1: 85–96
Studer RK, Borle AB (1980) The effects of hydrogen ions on the kinetics of calcium transport by rat kidney mitochondria. Arch Biochem Biophys 203: 707–718
Kristián T, Gidö G, Siesjö BK (1993) Brain calcium metabolism in hypoglycemic coma. J Cereb Blood Flow Metab 13: 955–961
Monyer H, Goldberg MP, Choi DW (1989) Glucose deprivation neuronal injury in cortical culture. Brain Res 483: 347–354
Nellgård B, Wieloch T (1992) Cerebral protection by AMPA- and NMDA-receptor antagonists administered after severe insulin-induced hypoglycemia. Exp Brain Res 92: 259–266
Siesjö BK, Deshpande JK (1987) Electrolyte shifts between brain and plasma in hypoglycemic coma. J Cereb Blood Flow Metab 7: 789–793
Auer RN, Hall P, Ingvar M, Siesjö BK (1986) Hypotension as a complication of hypoglycemia leads to enhanced energy failure but no increase in neuronal necrosis. Stroke 17: 442–449
Gibson GE, Mykytyn V (1988) An in vitro model of anoxic-induced damage in mouse brain. Neurochem Res 13: 9–20
Goldberg MP, Choi DW (1993) Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci 13: 3510–3524
Cheng B, Mattson MP (1992) IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. J Neurosci 12: 1558–1566
Ohta S, Smith M-L, Siesjö BK (1991) The effect of a dihydropyridine calcium antagonist (isradipine) on selective neuronal necrosis. J Neurol Sci 103: 109–115
Dubinsky JM (1993) Effects of calcium chelators on intracellular calcium and excitotoxicity. Neurosci Lett 150: 129–132
Tymianski M, Charlton MP, Carlen PL, Tator CH (1993) Source specificity of early calcium neurotoxicity in cultured embryonic spinal neurons. J Neurosci 13: 2085–2104
Hansson L (1990) Isradipine in hypertension. Drugs 40 [Suppl 2]: 10–14
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Auer, R.N., Anderson, L.G. Hypoglycaemic brain damage: effect of a dihydropyridine calcium channel antagonist in rats. Diabetologia 39, 129–134 (1996). https://doi.org/10.1007/BF00403954
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00403954